Compare Organon Pharma Indonesia Tbk. (SCPI) vs Siantar Top Tbk. (STTP) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Organon Pharma Indonesia Tbk. vs Siantar Top Tbk. — how do they compare? Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B), while Siantar Top Tbk. trades at Rp9,450 (market cap 12.31T, 1K 24h volume). The key difference: Siantar Top Tbk. is far larger — about 117.9× Organon Pharma Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.
| SCPI | STTP | |
|---|---|---|
Market Cap | 104.4B | 12.31T |
Volume | — | 1K |
Lot | — | 10 |
Turnover | — | 9.47M |
Average Price | — | 9,470 |
Value | — | 9.47M |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →About Siantar Top Tbk.
PT. Siantar Top Tbk (the Entity) was established based on Notarial Deed No. 45 dated May 12 1987 of Mrs. Endang Widjajanti, S.H., notary in Sidoarjo and was amended based on Notarial Deed No. 64 dated March 24, 1988 of the same notary.
Read more on STTP →
